|
Market Closed -
OTC Markets
01:29:24 05/06/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.008500 USD | +7.59% |
|
+13.33% | -10.53% |
| 15/08 | Evofem Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 01/07 | HUB Cyber Security Acquires Evofem Notes, Cuts Staff | MT |
| Market Cap | 10.27L 9L 8L 8L 14.19L 9.82Cr 14.32L 99.26L 38.2L 4.98Cr 38.57L 37.73L 16Cr | P/E 2024 |
-0.08x | P/E 2025 | 26.7x |
|---|---|---|---|---|---|
| Enterprise Value | 5.54Cr 4.77Cr 4.5Cr 4.1Cr 7.66Cr 530.09Cr 7.73Cr 54Cr 21Cr 268.87Cr 21Cr 20Cr 854.01Cr | EV / Sales 2024 |
2.43x | EV / Sales 2025 | 2.76x |
| Free-Float |
100% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +7.59% | ||
| 1 week | +13.33% | ||
| Current month | +3.03% | ||
| 1 month | +18.06% | ||
| 3 months | +13.33% | ||
| 6 months | -4.49% | ||
| Current year | -10.53% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0.01 | | 0.01 |
| Current year | 0 | | 0.01 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 0.23 |
| 5 years | 0 | | 1,593.75 |
| 10 years | 0 | | 23,549.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 01/01/2018 | |
Ivy Zhang
DFI | Director of Finance/CFO | 49 | 13/04/2023 |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | - | |
Colin Rutherford
BRD | Director/Board Member | 67 | 01/01/2018 |
Kim Kamdar
BRD | Director/Board Member | 58 | 01/01/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/01/24 | Sell | Chief Financial Officer | 104 | 0.0010% | ||
| 21/12/23 | Sell | Director | 10 | 0.0001% | ||
| 13/04/23 | Other | Chief Financial Officer | 13,000 | 0.0107% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.59% | +13.33% | -18.27% | -95.64% | 10.27L | |
| -0.11% | -3.16% | +48.82% | +91.49% | 1,00100Cr | |
| -0.27% | -4.34% | +51.52% | +65.89% | 64TCr | |
| +1.63% | -2.00% | +20.49% | +71.12% | 45TCr | |
| +0.35% | -2.83% | +29.25% | +36.63% | 34TCr | |
| +0.88% | -12.66% | +11.20% | +28.16% | 26TCr | |
| +0.66% | -1.36% | -0.94% | +12.77% | 25TCr | |
| -2.25% | -13.88% | +37.33% | +47.43% | 21TCr | |
| -2.28% | -6.31% | -19.04% | -59.05% | 20TCr | |
| -0.58% | -4.24% | +25.65% | +90.54% | 18TCr | |
| Average | +0.63% | -4.97% | +18.60% | +28.93% | 35.26TCr | |
| Weighted average by Cap. | +0.11% | -4.65% | +31.87% | +57.67% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.94Cr 1.67Cr 1.57Cr 1.43Cr 2.68Cr 185.13Cr 2.7Cr 19Cr 7.2Cr 94Cr 7.27Cr 7.11Cr 298.25Cr | 2.02Cr 1.74Cr 1.64Cr 1.49Cr 2.79Cr 192.97Cr 2.81Cr 20Cr 7.51Cr 98Cr 7.58Cr 7.41Cr 310.88Cr |
| Net income | -88.6L -76.2L -71.89L -65.49L -1.22Cr -85Cr -1.24Cr -8.56Cr -3.3Cr -43Cr -3.33Cr -3.25Cr -136.47Cr | 4L 3L 3L 3L 5L 3.74Cr 5L 37.79L 14.54L 1.9Cr 14.68L 14.36L 6.02Cr |
| Net Debt | 4.58Cr 3.94Cr 3.72Cr 3.39Cr 6.33Cr 438.27Cr 6.39Cr 44Cr 17Cr 222.3Cr 17Cr 17Cr 706.07Cr | 5.44Cr 4.68Cr 4.42Cr 4.02Cr 7.52Cr 520.27Cr 7.59Cr 53Cr 20Cr 263.89Cr 20Cr 20Cr 838.19Cr |
Employees
29
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/26/10 | $0.007750 | +6.16% | 12,529 |
| 09/26/09 | $0.007300 | +2.82% | 2,21,679 |
| 08/26/08 | $0.007100 | -7.79% | 6,43,430 |
| 04/26/04 | $0.007700 | +2.67% | 52,384 |
| 03/26/03 | $0.007500 | -6.25% | 2,64,387 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- EVFM Stock
Select your edition
All financial news and data tailored to specific country editions
